BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37195732)

  • 21. Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study.
    Nolasco S; Portacci A; Campisi R; Buonamico E; Pelaia C; Benfante A; Triggiani M; Spadaro G; Caiaffa MF; Scioscia G; Detoraki A; Valenti G; Papia F; Tomasello A; Crimi N; Scichilone N; Pelaia G; Carpagnano GE; Crimi C
    Front Immunol; 2023; 14():1204444. PubMed ID: 37457743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyangiitis overlap syndrome of granulomatosis with polyangiitis (Wegener's granulomatosis) and eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
    Uematsu H; Takata S; Sueishi K; Inoue H
    BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24577169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with Polyangiitis.
    Koike H; Nishi R; Yagi S; Furukawa S; Fukami Y; Iijima M; Katsuno M
    Adv Ther; 2023 Jan; 40(1):25-40. PubMed ID: 36152266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis.
    Martínez-Rivera C; Garcia-Olivé I; Urrutia-Royo B; Basagaña-Torrento M; Rosell A; Abad J
    BMC Pulm Med; 2021 Jan; 21(1):35. PubMed ID: 33478439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eosinophilic granulomatosis with polyangiitis evolution during severe eosinophilic asthma treatment with benralizumab.
    Hočevar A; Kopač P; Rotar Ž; Novljan MP; Škrgat S
    J Allergy Clin Immunol Pract; 2020; 8(7):2448-2449. PubMed ID: 32304835
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis.
    Bloom JL; Langford CA; Wechsler ME
    Rheum Dis Clin North Am; 2023 Aug; 49(3):563-584. PubMed ID: 37331733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eosinophilic granulomatosis with polyangiitis.
    Villa-Forte A
    Postgrad Med; 2023 Jan; 135(sup1):52-60. PubMed ID: 36259957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review.
    Raffray L; Guillevin L
    Drugs; 2018 Jun; 78(8):809-821. PubMed ID: 29766394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac tamponade leading to the diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a case report and review of the literature.
    Yano T; Ishimura S; Furukawa T; Koyama M; Tanaka M; Shimoshige S; Hashimoto A; Miura T
    Heart Vessels; 2015 Nov; 30(6):841-4. PubMed ID: 25070496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to mepolizumab according to disease manifestations in patients with eosinophilic granulomatosis with polyangiitis.
    Ríos-Garcés R; Prieto-González S; Hernández-Rodríguez J; Arismendi E; Alobid I; Penatti AE; Cid MC; Espígol-Frigolé G
    Eur J Intern Med; 2022 Jan; 95():61-66. PubMed ID: 34535374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.
    Groh M; Pagnoux C; Baldini C; Bel E; Bottero P; Cottin V; Dalhoff K; Dunogué B; Gross W; Holle J; Humbert M; Jayne D; Jennette JC; Lazor R; Mahr A; Merkel PA; Mouthon L; Sinico RA; Specks U; Vaglio A; Wechsler ME; Cordier JF; Guillevin L
    Eur J Intern Med; 2015 Sep; 26(7):545-53. PubMed ID: 25971154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
    Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
    J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Eosinophilic granulomatosis with polyangiitis presenting as livedo racemosa].
    Klossowski N; Vordenbäumen S; Sewerin P; Braun SA; Reifenberger J; Homey B; Meller S
    Hautarzt; 2014 Apr; 65(4):276-9. PubMed ID: 24700024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benralizumab for eosinophilic granulomatosis with polyangiitis.
    Cottu A; Groh M; Desaintjean C; Marchand-Adam S; Guillevin L; Puechal X; Beaumesnil S; Lazaro E; Samson M; Taille C; Durel CA; Diot E; Nicolas S; Guilleminault L; Ebbo M; Cathebras P; Dupin C; Yildiz H; Belfeki N; Pugnet G; Chauvin P; Jouneau S; Lifermann F; Martellosio JP; Cottin V; Terrier B;
    Ann Rheum Dis; 2023 Dec; 82(12):1580-1586. PubMed ID: 37550002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe cardiomyopathy revealing antineutrophil cytoplasmic antibodies-negative eosinophilic granulomatosis with polyangiitis.
    Bouiller K; Samson M; Eicher JC; Audia S; Berthier S; Leguy V; Humbert O; Martin L; Lorgis L; Cottin Y; Bonnotte B; Lorcerie B
    Intern Med J; 2014 Sep; 44(9):928-31. PubMed ID: 25201426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eosinophilic Granulomatosis with Polyangiitis Presenting with Central Retinal Artery Occlusion During Treatment with Anti-interleukin-5 Receptor Monoclonal Antibody.
    Nishiyama H; Tajiri T; Yamabe T; Yasukawa T; Takeda N; Fukumitsu K; Fukuda S; Kanemitsu Y; Uemura T; Ohkubo H; Takemura M; Maeno K; Ito Y; Oguri T; Naniwa T; Niimi A
    Intern Med; 2021 Nov; 60(22):3631-3634. PubMed ID: 34092731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertrophic pachymeningitis in eosinophilic granulomatosis with polyangiitis.
    Izuka S; Yamashita H; Takahashi Y; Kaneko H
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):80-82. PubMed ID: 34480185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eosinophilic granulomatosis with polyangiitis: Cutaneous clinical and histopathologic differential diagnosis.
    Tabb ES; Duncan LM; Nazarian RM
    J Cutan Pathol; 2021 Nov; 48(11):1379-1386. PubMed ID: 34019312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of T Helper Type 2 (Th2) Cytokines in the Pathogenesis of Eosinophilic Granulomatosis with Polyangiitis (eGPA): an Illustrative Case and Discussion.
    Milne ME; Kimball J; Tarrant TK; Al-Rohil RN; Leverenz DL
    Curr Allergy Asthma Rep; 2022 Nov; 22(11):141-150. PubMed ID: 36103081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two pediatric cases of ANCA-negative eosinophilic granulomatosis with polyangiitis successfully treated with dupilumab.
    Galant-Swafford J; Geng B; Leibel S; Akuthota P; Tucker S; Cernelc-Kohan M; Sheets R; Nation J; Jefferson AA
    J Allergy Clin Immunol Pract; 2020; 8(10):3643-3646.e1. PubMed ID: 32668296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.